CRSP
CRISPR Therapeutics AGData: 2026-09-04
Quick Stats
Sep 04, 202640.4
AI Score
HOLD0.61
Volume Ratio
TBA
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
CRSP Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
CRSP Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
CRSP Options - Sort by Max open Interest (near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRSP Daily Out of Money Options - Sort by Max open Interest (near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRSP Daily In the Money Options - Sort by Max open Interest (near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRSP Most Active Options by Volume(near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRSP Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CRSP Stock Summary
Last updated Sep 04, 2026
CRSP is currently trading at $55.79, positioned above its 200-day moving average of $53.24, indicating a long-term uptrend. The stock has a 52-week range of $44.12 to $78.48.
Technical Analysis: The 50-day moving average stands at $53.76, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 50.577, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.057, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CRSP at 40.4/100 with a HOLD recommendation.
CRSP (CRISPR Therapeutics AG) Indicators
Last updated Sep 04, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.577 |
| CMF (20) | 0.057 |
| ROC (10) | -6.235 |
| ADX (14) | 28.959 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.233 |
| AROONOSC (14) | 21.429 |
| WILLAMS %R (14) | -62.832 |
| MFI (14) | 54.273 |
CRISPR Therapeutics AG is above both the 50 Day and 200 Day SMA which is considered Bullish.
CRSP Moving Averages Analysis
CRISPR Therapeutics AG has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 04, 2026
CRISPR Therapeutics AG has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 04, 2026
CRSP (CRISPR Therapeutics AG) Simple Moving Averages
Moving Averages are last updated Sep 04, 2026
| Days | MA |
|---|---|
| 10 | 57.73 |
| 20 | 56.55 |
| 30 | 54.32 |
| 50 | 53.76 |
| 100 | 53.27 |
| 200 | 53.24 |
CRSP Fundamental Analysis
| P/E (Forward) | 25 |
| P/E (Trailing) | -- |
| Market Cap ($) | 5.5 billion |
| Earnings/Share ($) | -4.67 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.4465 |
| EPS Estimate Next Year ($) | -3.4973 |
| WallStreet Target Price ($) | 87.56 |
| Most Recent Quarter |
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.